The MarketWatch News Department was not involved in the creation of this content. Accomplished RNA therapeutics leader with track record of advancing novel genetic medicines from discovery to FDA ...
Accomplished RNA therapeutics leader with track record of advancing novel genetic medicines from discovery to FDA approval to lead research and development at Flashpoint EVANSTON, Ill.--(BUSINESS WIRE ...
Accomplished RNA therapeutics leader with track record of advancing novel genetic medicines from discovery to FDA approval to lead research and development at Flashpoint Flashpoint Therapeutics, a ...
Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results